BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Small Cap Pro

1 year 30%, 2 years 40% and *3 years 50%

*Across 3 years $2158.56 only $1079.28

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,032.38
      0.56%
      US Tech 100
      20,389.60
      0.88%
      Dow Jones
      44,910.65
      0.42%
      Brent Oil
      71.98
      -0.08%
      Bitcoin
      96,666.97
      -0.84%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Shattuck Labs Inc (STTK)

      7. Shattuck Labs Inc (STTK) News

      Shattuck Labs Inc

      Shattuck Labs Inc (STTK)

      NASDAQ
      1.10
      0.01
      (0.92%)
      Closed November 30 4:00PM
      Delayed by 15 minutes
      1.10
      0.00
      (0.00%)
      After Hours: 3:59PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      STTK News

      Official News Only

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 14 2024
      STTK (0.92%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 14 2024
      STTK (0.92%)

      Form SC 13G - Statement of Beneficial Ownership by Certain Investors
      Edgar (US Regulatory)
      November 08 2024
      STTK (0.92%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      October 01 2024
      STTK (0.92%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      August 01 2024
      STTK (0.92%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      August 01 2024
      STTK (0.92%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 14 2024
      STTK (0.92%)

      Form 8-K/A - Current report: [Amend]
      Edgar (US Regulatory)
      June 11 2024
      STTK (0.92%)

      STTK Discussion

      View Posts
      TrendTrade2016 TrendTrade2016 2 months ago
      STTK COMING OFF BOTTOM
      👍️0
      glenn1919 glenn1919 2 months ago
      STTK............................https://stockcharts.com/h-sc/ui?s=STTK&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 3 months ago
      STTK under $4
      👍️0
      PonkenPlonken PonkenPlonken 6 months ago
      absolutely revolutionary data in HR MDS... compare to SOC!!! HMAs show a ORR 30%, CR 10-20%
      (also beats venetoclax + HMA in TP53m AML)

      Observed 79% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial complete response (CR)/marrow complete response (mCR) rate of 64% –

      – Observed 27% initial CR/complete response with incomplete hematologic recovery (CRi) in frontline TP53m AML patients, and 5/11 evaluable patients achieved stable disease with decreasing blast counts and peripheral blood count improvement, these patients continue on treatment
      👍️0
      Monksdream Monksdream 7 months ago
      STTK new 52 week high
      👍️0
      Monksdream Monksdream 11 months ago
      STTK new 52 week high
      👍️0
      Monksdream Monksdream 11 months ago
      STTK new 52 week low
      👍️0
      tbonaces80 tbonaces80 12 months ago
      Takeda gonna tender on next trial fast track
      👍️0
      tbonaces80 tbonaces80 12 months ago
      load it-going to 10+
      👍️0
      subslover subslover 12 months ago
      No fooling? So you say a 1.75% profit for a two-hour trade is a bad trade?
      👍️0
      tbonaces80 tbonaces80 12 months ago
      Bad trade
      👍️0
      subslover subslover 12 months ago
      Ok. I got out of this POS this morning at $5.00, got lucky is all
      👍️0
      TheFinalCD TheFinalCD 12 months ago
      @ 4.29 I was just looking for a move under $4 and it did

      small gain, but I didnt know how many borrows I could get if it went against me

      sometimes I go short, and get upside down and cant average up, because broker all of a sudden has NO available shares to short= your stuck

      so thats why I dont short much
      👍️0
      subslover subslover 12 months ago
      What price did you short?tia
      👍️0
      TheFinalCD TheFinalCD 12 months ago
      I shorted it... Its just Phase 1

      AI bot hyper extended the POP

      I used to chase these Pase 1 rallys, lost lots of money doing so

      some of my biggest losses ever

      Phase 1 Gap & Traps
      👍️0
      subslover subslover 12 months ago
      Did you see this open? $7.28! then immediately dropped down to $2.50 omg. I'm in at $3.00 just hoping for the best. Worth a shot
      👍️0
      TheFinalCD TheFinalCD 12 months ago
      https://twitter.com/TigerLineTrades/status/1734900423301988796
      👍️0
      subslover subslover 12 months ago
      $TSOI's new Introducing the ALScell™, also known as the JadiCell™ – Now, these ALScells are not your run-of-the-mill mesenchymal stem cells; they're basically the overachievers of the cellular world. These ALScells have it all – enhanced growth factor production, like they've been hitting the gym and drinking protein shakes on a regular basis. They can secrete exosomes , outshining their stem cell peers who are still trying to figure out how to tie their cellular shoelaces.

      But wait, there's more! These ALScells are not just content with being academically gifted; they've got some serious street smarts too. Superior angiogenic and neurogenic abilities mean they're like the cool kids who not only excel in science class but also throw legendary parties in the cellular neighborhood.

      And guess what? Exosomes are not just a fancy word; they're the VIP pass to the cure of many cancers. It's like the ALScells are hosting the party, and exosomes are the invitations that cancer cells can't resist.

      So, say hello to the ALScell™ – the cellular superhero ready to save the day, one enhanced growth factor at a time, and unlocking cures like a boss!
      Bullish
      BULLISH
      👍️0
      Awl416 Awl416 12 months ago
      Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Pati
      👍️0
      Monksdream Monksdream 1 year ago
      STTK under $2
      👍️0

      Your Recent History

      NASDAQ
      STTK
      Shattuck Labs
      Delayed Upgrade Clock